Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000914190-21-000181

Chief Financial Officer sold 9,942 shares at an average $421.93 ($4,194,831)

  • Chief Financial Officer acquired 9,942 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Hippel James · Chief Financial Officer

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2021-06-07 Exercise or conversion : show line 1 in the form +9,942 $106.59 $1,059,718 19,079 D
2021-06-07 Sale : show line 2 in the form −1,507 $419.88 $632,765 17,572 D
2021-06-07 Sale : show line 3 in the form −2,029 $420.66 $853,523 15,543 D
2021-06-07 Sale : show line 4 in the form −2,396 $421.93 $1,010,935 13,147 D
2021-06-07 Sale : show line 5 in the form −2,000 $422.81 $845,628 11,147 D
2021-06-07 Sale : show line 6 in the form −1,700 $423.74 $720,357 9,447 D
2021-06-07 Sale : show line 7 in the form −310 $424.59 $131,623 9,137 D
Open-market sales · 9,942 sh · avg $421.93 · $4,194,831

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-06-07 Exercise or conversion : show line 8 in the form Stock Options (Right to Buy) −9,942 30,000 D
Loading xslF345X03/edgar.xml…